The Value of Botox-A for Management of Low Anterior Resection Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Low Anterior Resection SyndromeRectal Cancer
Interventions
DRUG

intra-rectal Botulinum toxin A injection

intra-colic injection of 100 U of Botulinum toxin A as a single injection distributed amongst the four quadrants, 5 cm above anastomosis

Trial Locations (1)

H2X 3J4

Centre Hospitalier Universitaire de Montréal, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER